Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | HTR6 | P50406 | 1/20 | 0.43 |
| ▸ | SRC | P12931 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | DPP4 | P27487 | 2/20 | 0.38 |
| ▸ | F2 | P00734 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL780336 | 0.78 | CYP2C19 (0.52) | CYP2C19HTR6SRCALDH1A1CYP2D6 | |
| Potassium SCHEMBL29685977 | 0.76 | CYP2C19 (0.50) | CYP2C19HTR6SRCALDH1A1CYP2D6 | |
| SCHEMBL9124179 | 0.76 | CYP2C19 (0.50) | CYP2C19HTR6SRCALDH1A1CYP2D6 | |
| SCHEMBL1272692 | 0.74 | CYP2C19 (0.48) | CYP2C19HTR6SRCALDH1A1CYP2D6 | |
| SCHEMBL496890 | 0.74 | SRC (0.58) | CYP2C19SRCALDH1A1CYP2D6TSHR | |
| SCHEMBL5886893 | 0.74 | CYP2C19 (0.48) | CYP2C19HTR6SRCALDH1A1CYP2D6 | |
| SCHEMBL8520306 | 0.74 | CYP2C19 (0.48) | CYP2C19HTR6SRCALDH1A1CYP2D6 | |
| SCHEMBL3637962 | 0.74 | CYP2C19 (0.48) | CYP2C19SRCALDH1A1CYP2D6DPP4 | |
| SCHEMBL6050266 | 0.74 | CYP2C19 (0.48) | CYP2C19HTR6SRCALDH1A1CYP2D6 | |
| SCHEMBL27492041 | 0.74 | CYP2C19 (0.48) | CYP2C19HTR6SRCALDH1A1CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2356182-B1 | RADIATION CURABLE COATING MATERIALS | BASF SE (DE) | 2015-05-06 | — | — | EP | disclosed |
| US-20130299736-A1 | RADIATION-CURABLE COATING MATERIALS | BASE SE (DE) | 2013-11-14 | — | — | US | disclosed |
| US-20110230617-A1 | RADIATION-CURABLE COATING MATERIALS | BASF SE (DE) | 2011-09-22 | — | — | US | disclosed |
| EP-2356182-A1 | RADIATION CURABLE COATING MATERIALS | BASF SE (DE) | 2011-08-17 | — | — | EP | disclosed |
| CN-101069129-B | Radiation-curable coating substances | BASF AG | 2010-12-08 | — | — | CN | disclosed |
| US-20100126386-A1 | RADIATION-CURABLE COATING SUBSTANCES | BASF AKTIENGESELLSCHAFT (DE) | 2010-05-27 | — | — | US | disclosed |
| WO-2010055050-A1 | RADIATION CURABLE COATING MATERIALS | BASF SE (DE) | 2010-05-20 | — | — | WO | disclosed |
| WO-2008058885-A2 | RADIATION-HARDENABLE COATING MASSES | BASF SE (DE) | 2008-05-22 | — | — | WO | disclosed |
| WO-2007138095-A1 | USE OF STABILIZING COMPOSITIONS CONTAINING CYANINE CATIONS IN PACKAGING MATERIALS | BASF SE (DE) | 2007-12-06 | — | — | WO | disclosed |
| CN-101069129-A | Radiation-curable coating substances | BASF AG (DE) | 2007-11-07 | — | — | CN | disclosed |
| EP-1820064-A2 | RADIATION-CURABLE COATING SUBSTANCES | BASF AKTIENGESELLSCHAFT (DE) | 2007-08-22 | — | — | EP | disclosed |
| WO-2006058731-A2 | RADIATION-CURABLE COATING SUBSTANCES | BASF AKTIENGESELLSCHAFT (DE) | 2006-06-08 | — | — | WO | disclosed |
| US-6110987-A | CURED PRODUCTS HAVING AN EXCELLENT APPEARANCE WITHOUT COLORING CAUSED BY POLYMERIZATION INITIATOR | SHOWA DENKO K.K. (JP) | 2000-08-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110230617-A1 | RADIATION-CURABLE COATING MATERIALS | RAD51, MGMT, RAD54L | CYP2C19 3154/4885HTR6 2274/4885SRC 2759/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.